Clinical Trial Update: Immunohistochemical Staining of p16 for the Screening of Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunohistochemical staining of p16 for screening cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Lei Li | Conditions: Cervical Cancer Screening, p16 Protein | Phase 2 | Status: UNKNOWN